Gels is a distinguished, peer-reviewed journal published by MDPI, focusing on the innovative field of gels and their myriad applications across disciplines such as bioengineering, biomaterials, and organic chemistry. Since its inception in 2015, this Open Access journal has provided a platform for researchers to disseminate cutting-edge findings, enabling wider visibility and impact for their work. Based in Switzerland, Gels has firmly established itself within the academic community, achieving notable recognition as evidenced by its recent Q1 ranking in Polymers and Plastics, and multiple Q2 placements in related categories, demonstrating its relevance and importance in the field. The journal serves as a vital resource for professionals and scholars aiming to engage with the rapidly evolving research landscape surrounding gel technologies, making significant contributions to sustainable materials, drug delivery systems, and much more. With its commitment to Open Access, Gels ensures that research findings are readily accessible to all stakeholders, fostering collaboration and advancement in science and engineering fields.

Nature Biomedical Engineering is a premier journal published by NATURE PORTFOLIO, focusing on innovative research at the intersection of engineering and biomedical sciences. With an ISSN of 2157-846X, this journal aims to disseminate groundbreaking studies that advance the field of bioengineering, biotechnology, and medical applications. Since its inception in 2017, it has rapidly earned a reputation for excellence, consistently achieving a Q1 ranking in various categories including Bioengineering and Biomedical Engineering, and receiving acclaim in prestigious Scopus rankings, boasting top positions in the fields of Computer Science Applications and Medicine. The journal operates under a rigorous peer-review process, ensuring that all published articles contribute substantially to the existing body of knowledge. Furthermore, it facilitates a broad accessibility model for researchers and practitioners, bolstering collaboration and innovation within the global scientific community. Nature Biomedical Engineering is not just a publication; it serves as a vital platform for thought leadership in the transformative field of biomedical engineering.

Microsystems & Nanoengineering, published by SpringerNature, stands at the forefront of advancing knowledge in the fields of atomic and molecular physics, condensed matter physics, electrical and electronic engineering, and materials science. With an impressive impact factor and categorized in Q1 across multiple prestigious fields in 2023, this journal not only provides a platform for high-quality research but also reflects the vitality of innovations within these disciplines. Since its transition to Open Access in 2015, it has significantly broadened accessibility for researchers, professionals, and students globally, facilitating the dissemination of groundbreaking findings. Addressed in the United Kingdom, with a focus on interdisciplinary collaboration, Microsystems & Nanoengineering aims to foster connections between theoretical advancements and practical applications, serving as a crucial resource for those engaged in cutting-edge nanoscale technologies and microsystems development. Immerse yourself in the latest studies and engage with the vibrant community that shapes the future of science and engineering.

Innovation and Emerging Technologies, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is a cutting-edge journal dedicated to advancing knowledge in the fields of technology, innovation, and their applications across various sectors. With ISSN 2737-5994 and E-ISSN 2810-9007, this journal aims to serve as a comprehensive platform for scholarly research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although specific metrics such as impact factor and H-index are currently unavailable, the journal is poised to make significant contributions to the discourse surrounding emerging technologies and their societal implications. Emphasizing the importance of accessibility, the journal offers a range of options for engaging with its content, encouraging a wide readership and promoting the exchange of innovative ideas. Situated in Singapore, the journal reflects the region's commitment to technological advancement and global research, making it a pivotal resource for those dedicated to exploring the future of technology.

Journal of Optoelectronic and Biomedical Materials (ISSN: 2066-0049) is a peer-reviewed academic journal published by the renowned VIRTUAL INSTITUTE OF PHYSICS, dedicated to advancing research in the interdisciplinary fields of optoelectronics and biomedical materials. This journal aims to provide a platform for researchers, professionals, and students to disseminate their findings on innovative materials and technologies that harness optical and electronic properties for biomedical applications. With an increasing significance in medical diagnostics, therapeutic approaches, and advanced materials science, the Journal of Optoelectronic and Biomedical Materials underscores the importance of facilitating collaboration among scientists from diverse fields. While currently operating under a traditional access model, the journal aspires to enhance global accessibility to cutting-edge research contributions that will drive the future of technology in healthcare and biotechnology. As a growing reference point in its domain, it encourages submissions that can advance these crucial scientific areas.

Annual Review of Biomedical Data Science, published by ANNUAL REVIEWS, stands as a premier journal in the fields of Biomedical Engineering, Biochemistry, Genetics, and Cancer Research, with an impressive Q1 ranking across these categories in 2023. With its ISSN and e-ISSN both assigned as 2574-3414, this journal serves as a critical resource for researchers, professionals, and students looking to delve into comprehensive reviews of the rapidly evolving landscape of biomedical data science. The journal's scope includes the intersection of data science methodologies and biomedical applications, making it essential for those aiming to stay at the forefront of innovations that drive advancements in healthcare and medical research. Although it currently does not provide open access options, its commitment to high-quality research and its robust rankings—placing it in the 94th percentile in its field—underscore its significance and credibility in the academic community. Operating from the United States, with its offices located in Palo Alto, CA, this journal is a vital contributor to the discourse on the integration of data science within biomedical fields, fostering collaboration and knowledge dissemination among scholars worldwide.

BIOSENSORS & BIOELECTRONICS, published by Elsevier Advanced Technology, is at the forefront of research and innovation in the realms of biomedical engineering, biophysics, and biotechnology. Established in 1990, this esteemed journal has established itself as a premier platform, receiving a prestigious Q1 ranking across multiple categories, including Electrochemistry and Nanoscience, reflecting its critical impact on advancing scientific knowledge and technology. With an impressive range of topics, including the latest trends in biosensor development and bioelectronic application, it serves as an invaluable resource for researchers, professionals, and students alike, facilitating collaborative dialogue and innovative solutions. Though primarily subscription-based, the journal is accessible from its UK headquarters in Oxford, promising rigorous peer-reviewed articles that inform future trends and applications in this dynamic field.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

Biomicrofluidics is a leading academic journal published by AIP Publishing, dedicated to disseminating cutting-edge research in the interface of microfluidics and biotechnology. Established in 2007 and continuing through 2024, this journal serves as a vital resource for researchers and professionals across various fields, including Biomedical Engineering, Colloid and Surface Chemistry, Condensed Matter Physics, and Nanoscience. With impactful insights and innovative methodologies, it maintains a commendable reputation, reflected in its impressive Scopus rankings, such as 24th in Fluid Flow and Transfer Processes and 10th in Colloid and Surface Chemistry. Although not an open-access journal, Biomicrofluidics ensures accessibility to its valuable content through various subscription options, facilitating knowledge sharing in scientific communities. This journal is essential for those at the forefront of microfluidic technologies and applications, offering a platform for exploring novel approaches and driving advancement in biomedical and engineering sciences.

Advanced Biomedical Engineering is a peer-reviewed open access journal published by the Japanese Society for Medical & Biological Engineering, dedicated to disseminating high-quality research in the multidisciplinary fields of biomedical engineering. Boasting an ISSN of 2187-5219, this journal has been pivotal since its inception in 2018, especially as it embraces the open access model to foster knowledge sharing and wide accessibility. Centered in Tokyo, Japan, it serves as a vital platform for scholars and practitioners across various domains, such as biomaterials, biomedical engineering, and biotechnology. Despite currently residing in the Q4 quartile across several categories, including those in biotechnology and computer science applications, the journal is committed to elevating its academic impact and reputation, aiming for improved rankings in Scopus and other databases. Researchers and professionals are encouraged to contribute their innovative findings, discussions, and case studies, facilitating the advancement of this dynamic field.